MARKET

OFIX

OFIX

Orthofix Medical
NASDAQ

Real-time Quotes | Nasdaq Last Sale

38.97
-1.69
-4.16%
Closed 16:06 09/20 EDT
OPEN
40.17
PREV CLOSE
40.66
HIGH
40.26
LOW
38.56
VOLUME
84.99K
TURNOVER
--
52 WEEK HIGH
48.50
52 WEEK LOW
28.32
MARKET CAP
767.51M
P/E (TTM)
-92.8963
1D
5D
1M
3M
1Y
5Y
Orthofix Medical Launches Magnesium-Based Settable Bone Void Filler
MT Newswires · 3h ago
Orthofix Announces Participation in Upcoming Sidoti Virtual Investor Conference
LEWISVILLE, Texas, September 20, 2021--Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice w...
Business Wire · 1d ago
Orthofix Medical's Return on Invested Capital Insights
According to Benzinga Pro, during Q2, Orthofix Medical (NASDAQ:OFIX) earned $4.27 million, a 246.33% increase from the preceding quarter. Orthofix Medical also posted a total of $121.39 million in sales, a 14.96% increase since Q1.
Benzinga · 09/09 17:15
Orthofix (OFIX) Fitbone Used in 1st US Pediatric Patient Implant
Zacks.com · 09/02 13:07
BRIEF-Orthofix Medical Inc Announces First Us Pediatric Implant Of Fitbone Limb-Lengthening System
reuters.com · 09/01 13:04
Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced the first U.S. pediatric patient implanted with the Fitbone™ intramedullary lengthening
Benzinga · 09/01 11:04
4 Small-Cap Medical Device Stocks Rated 'Strong Buy'
StockNews.com · 08/25 13:51
How Much Did Orthofix Medical's(NASDAQ:OFIX) Shareholders Earn From Share Price Movements Over The Last Three Years?
Many investors define successful investing as beating the market average over the long term. But in any portfolio...
Simply Wall St. · 08/09 12:46
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of OFIX. Analyze the recent business situations of Orthofix Medical through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average OFIX stock price target is 54.38 with a high estimate of 58.00 and a low estimate of 51.00.
EPS
Institutional Holdings
Institutions: 210
Institutional Holdings: 20.89M
% Owned: 106.06%
Shares Outstanding: 19.69M
TypeInstitutionsShares
Increased
60
846.17K
New
11
274.09K
Decreased
48
693.45K
Sold Out
17
376.59K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-1.45%
Healthcare Equipment & Supplies
-1.59%
Key Executives
President/Chief Executive Officer/Director
Jon Serbousek
Chief Financial Officer
Douglas Rice
Corporate Executive
Paul Gonsalves
Corporate Executive
Kevin Kenny
Other
Kimberley Elting
Independent Director
Jason Hannon
Independent Director
James Hinrichs
Independent Director
Lilly Marks
Independent Director
Michael Paolucci
Independent Director
John Sicard
No Data
  • All
  • Financials
  • Insiders
More
About OFIX
Orthofix Medical Inc., formerly Orthofix International N.V., is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim. The Biologics products include AlloQuent Structural Allografts, Trinity ELITE, Trinity Evolution and VersaShield. The Extremity Fixation products include Fixator, Eight-Plate Guided Growth System and Contours VPS Volar Plating System III. The Spine Fixation products include Hallmark Anterior Cervical Plate System, Ascent LE Posterior Occipital Cervico-Thoracic (POCT) System, Firebird Deformity Correction System, Phoenix Minimally Invasive Spinal Fixation System, LONESTAR Cervical Stand Alone (CSA), SKYHAWK Lateral Interbody Fusion System & Lateral Plate System and CENTURION POCT System.

Webull offers kinds of Orthofix Medical Inc stock information, including NASDAQ:OFIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OFIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading OFIX stock methods without spending real money on the virtual paper trading platform.